Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared a post on X:
“NICE 2026 Kidney Cancer Guideline – What’s new?
- More biopsy – fewer unnecessary surgeries
- Active surveillance in small tumors – less overtreatment
- Risk-adapted follow-up – fewer unnecessary scans
Less aggressive, smarter, and more personalized kidney cancer care.”
Title: NICE 2026 guideline for the diagnosis and management of kidney cancer
Authors: Grant D. Stewart, Sarah Boyce, Marie C. Harrisingh, Olivia Crane
Read the Full Article.
Other articles featuring Ahmet Dirican on OncoDaily.
